Array-based comparative genomic hybridization in early-stage mycosis fungoides: Recurrent deletion of tumor suppressor genes BCL7A, SMAC/DIABLO, and RHOF

Genes Chromosomes and Cancer

Volumn 47, Issue 12, 2008, Pages 1067-1075

  Carbone, Angelo ^a,c   Bernardini, Laura ^b   Valenzano, Francesco ^a   Bottillo, Irene ^b   De Simone, Clara ^a   Capizzi, Rodolfo ^a   Capalbo, Anna ^b   Romano, Francesca ^b   Novelli, Antonio ^b   Dallapiccola, Bruno ^b   Amerio, Pierluigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BCL7A GENE; BLOOD; CANCER CELL; CHROMOSOME 12Q; CHROMOSOME 16Q; CHROMOSOME 19; CHROMOSOME 21Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DIABLO GENE; FEMALE; GENE DELETION; GENE IDENTIFICATION; HEMATOLOGIC MALIGNANCY; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MALE; MYCOSIS FUNGOIDES; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHOF GENE; SKIN; SKIN BIOPSY; SMAC GENE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; FEMALE; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MYCOSIS FUNGOIDES; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; RHO GTP-BINDING PROTEINS; SKIN NEOPLASMS;

EID: 57149107372     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20601     Document Type: Article

References (43)

1. Adnane J, Muro-Cacho C, Mathews L, Sebti SM, Muñoz-Antonia T. 2002. Suppression of RhoB expression in invasive carcinoma from head and neck cancer patients. Clin Cancer Res 8:2225-2232.
2. Batista DA, Vonderheid EC, Hawkins A, Morsberger L, Long P, Murphy KM, Griffin CA. 2006. Multicolor fluorescence in situ hybridization (SKY) in mycosis fungoides and Sézary syndrome: Search for recurrent chromosome abnormalities. Genes Chromosomes Cancer 45:383-391.
3. Bektic J, Pfeil K, Berger AP, Ramoner R, Pelzer A, Schäfer G, Kofler K, Bartsch G, Klocker H. 2005. Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis. Prostate 64:332-340.
4. Clark EA, Golub TR, Lander ES, Hynes RO. 2000. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406:532-535.
5. Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock R. 1998. Transformation of mycosis fungoides/Sezary sindrome: Clinical characteristics and prognosis. Blood 92:1150-1159.
6. Ellis S, Mellor H. 2000. The novel Rho-family GTPase Rif regulates coordinated actin-based membrane rearrangements. Curr Biol 10:1387-1390.
7. Fischer TC, Gellrich S, Muche JM, Sherev T, Audring H, Neitzel H, Walden P, Sterry W, Tönnies H. 2004. Genomic aberrations and survival in cutaneous Tcell lymphomas. J Investig Dermatol 122:579-586.
8. Forget MA, Desrosiers RR, Del M, Moumdjian R, Shedid D, Berthelet F, Béliveau R. 2002. The expression of Rho-proteins decreases with human brain tumour progression: Potential tumour marker. Clin Exp Metastasis 19:9-15.
9. Gouw LG, Reading NS, Jenson SD, Lim MS, Elenitoba-Johnson KS. 2005. Expression of the Rho-family GTPase gene RHOF in lymphocyte subsets and malignant lymphomas. Br J Haematol 129:531-533.
10. Hahtola S, Tuomela S, Elo L, Häkkinen T, Karenko L, Nedoszytko B, Heikkilä H, Saarialho-Kere U, Roszkiewicz J, Aittokallio T, Lahesmaa R, Ranki A. 2006. Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma. Clin Cancer Res 12:4812-4821.
11. Hwang ST, Janik JE, Jaffe ES, Wilson WH. 2008. Mycosis fungoides and Sezary syndrome. Lancet 371:945-958.
12. Kamai T, Kawakami S, Koga F, Arai G, Takagi K, Arai K, Tsujii T, Yoshida KI. 2003. RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. BJU Int 91:234-238.
13. Karenko L, Hyytinen E, Sarna S, Ranki A. 1997. Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods. J Investig Dermatol 108:22-29.
14. Karenko L, Sarna S, Kähkönen M, Ranki A. 2003. Chromosomal abnormalities in relation to clinical disease in patients with cutaneous T-cell lymphoma: A 5-year follow-up study. Br J Dermatol 148:55-64.
15. Karenko L, Hahtola S, Päivinen S, Karhu R, Syrjä S, Kähkönen M, Nedoszytko B, Kytölä S, Zhou Y, Blazevic V, Pesonen M, Nevala H, Nupponen N, Sihto H, Krebs I, Poustka A, Roszkiewicz J, Saksela K, Peterson P, Visakorpi T, Ranki A. 2005. Primary cutaneous T-cell lymphomas show a deletion or traslocation affecting NAV3, the human UNC-53 homologue. Cancer Res 65:8101-8110.
16. Kitamura Y, Shimizu K, Ito K, Tanaka S, Emi M. 2000. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q. Genes Chromosomes Cancer 27:244-251.
17. Liu N, Zhang G, Bi F, Pan Y, Xue Y, Shi Y, Yao L, Zhao L, Zheng Y, Fan D. 2007. RhoC is essential for the metastasis of gastric cancer. J Mol Med 85:1149-1156.
18. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
19. Mao X, Lillington D, Scarisbrick JJ, Mitchell T, Czepulkowski B, Russell-Jones R, Young B, Whittaker SJ. 2002. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: Identification of common genetic alterations in Sezary syndrome and mycosis fungoides. Br J Dermatol 147:464-475.
20. Mao X, Lillington DM, Czepulkowski B, Russell-Jones R, Young BD, Whittaker S. 2003a. Molecular cytogenetic characterization of Sezary syndrome. Genes Chromosomes Cancer 36:250-260.
21. Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker SJ. 2003b. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood 101:1513-1519.
22. Martinez-Delgado B, Melendez B, Cuadros M, Jose Garcia M, Nomdedeu J, Rivas C, Fernandez-Piqueras J, Benítez J. 2004. Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res 10:4971-4982.
23. Mazieres J, Antonia T, Daste G, Muro-Cacho C, Berchery D, Tillement V, Pradines A, Sebti S, Favre G. 2004. Loss of RhoB expression in human lung cancer progression. Clin Cancer Res 10:2742-2750.
24. Nowell PC, Vonderheid EC, Besa E, Hoxie JA, Moreau L, Finan JB. 1986. The most common chromosome change in 86 chronic B cell or Tcell tumors: a 14q32 traslocation. Cancer Genet Cytogen 19:219-227.
25. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, Zackeim H, Duvic M, Estrach T, Lamberg S, Wood G, Dummer R, Ranki A, Burg G, Heald P, Pittelkow M, Bernengo MG, Stery W, Laroche L, Trautinger F, Whittaker S, ISCL/EORTC. 2007. Revisions to the staging and clasification of mycosis fungoides and Sezary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110:1713-1722.
26. Pellegrin S, Mellor H. 2005. The Rho-family GTPase Rif induces filopodia through mDia2. Curr Biol 15:129-133.
27. Prochazkova M, Chevret E, Mainhaguiet G, Sobotka J, Vergier B, Belaud-Rotureau MA, Beylot-Barry M, Merlio JP. 2007. Common chromosomal abnormalities in mycosis fungoides transformation. Genes Chromosomes Cancer 46:828-838.
28. Sahai E, Marshall CJ. 2002. Rho-GTPases and cancer. Nat Rev Cancer 2:133-142.
29. Sato N, Fukui T, Taniguchi T, Yokoyama T, Kondo M, Nagasaka T, Goto Y, Gao W, Ueda Y, Yokoi K, Minna JD, Osada H, Kondo Y, Sekido Y. 2007. RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line. Int J Cancer 120:543-551.
30. Siegel RS, Pandolfino T, Guitart J, Rosen S, Kuzel TM. 2000. Primary cutaneous T-cell lymphoma: Review and current concepts. J Clin Oncol 18:2908-2925.
31. Sterry W. 2006. Cutaneous T-cell lymphoma: Molecular and cytogenetic findings. Oncology 21:1-5.
32. Thangavelu M, Finn WG, Yelavarthi KK, Roenigk HH Jr., Samuelson E, Peterson L, Kuzel TM, Rosen ST. 1997. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/ Sezary syndrome. Blood 189:3371-3377.
33. Tracey L, Villuendas R, Dotor AM, Spiteri I, Ortiz P, Garcia JF, Peralto JL, Lawler M, Piris MA. 2003. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signalling pathway. Blood 102:1042-1050.
34. Trost D, Ehrler M, Fimmers R. 2007. Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors. Int J Cancer 120:2368-2376.
35. Väkevä L, Pukkala E, Ranki A. 2000. Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma. J Investig Dermatol 115:62-65.
36. van Doorn R, Zoutman WH, Dijkman R, de Menezes RX, Commandeur S, Mulder AA, van der Velden PA, Vermeer MH, Willemze R, Yan PS, Huang TH, Tensen CP. 2005. Epigenetic profiling of cutaneous T-cell lymphoma: Promoter hypermethylation of multiple tumor suppressor genes including BCL7A, PTPRG and p73. J Clin Oncol 23:3886-3896.
37. Vergier B, de Muret A, Beylot-Barry M, Vaillant L, Ekouevi D, Chene G, Carlotti A, Franck N, Dechelotte P, Souteyrand P, Courville P, Joly P, Delaunay M, Bagot M, Grange F, Fraitag S, Bosq J, Petrella T, Durlach A, De Mascarel A, Merlio JP, Wechsler J. 2000. Transformation of mycosis fungoides: Clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneous Lymphomas. Blood 95:2212-2218.
38. Vermeer MH, van Doorn R, Dijkman R, Mao X, Whittaker S, van Voorst Vader PC, Gerritsen MJP, Geerts ML, Gellrich S, Söderberg O, Leuchowius KJ, Landegren U, Out-Luiting JJ, Knijnenburg J, Ijszenga M, Szuhai K, Willemze R, and Tensen CP. 2008. Novel and highly recurrent chromosomal alterations in Sézary Syndrome. Cancer Res 68:2689-2698.
39. Vonderheid EC, Bernengo MG, Burg G, Duvic M, Heald P, Laroche L, Olsen E, Pittelkow M, Russell-Jones R, Takigawa M, Willemze R, ISCL. 2002. Update on erythrodermic cutaneous T-cell lymphoma: report on the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 46:95-106.
40. Weinstock MA, Horm JW. 1988. Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. J Am Med Assoc 260:42-46.
41. Whang-Peng J, Bunn PA Jr., Knutsen T, Matthews MJ, Schechter G, Minna JD. 1982. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer 50:1539-1553.
42. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ. 2005. WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768-3785.
43. Yoo NJ, Kim HS, Kim SY, Park WS, Park CH, Jeon HM, Jung ES, Lee JY, Lee SH. 2003. Immunohistochemical analysis of Smac/DIABLO expression in human carcinomas and sarcomas. APMIS 111:382-388.